Found 6 matching trials
Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP
PHASE2This is a multicenter study for the long-term follow-up of surviving patien...
Location
Multiple Locations
Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP
PHASE2The purpose of this study is to determine the safety and effectiveness of u...
Location
Rush Medical Center
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
PHASE2The primary efficacy endpoint of this study is to determine the duration of...
Location
Multiple Locations
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
PHASE3RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer...
Location
Alaska Regional Hospital Cancer Center
S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
PHASE2RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Location
MBCCOP - University of South Alabama
Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma
PHASE1Mantle cell lymphoma (MCL) is a rare and aggressive type of lymphoma, with ...
Location
Memorial Sloan Kettering at Basking Ridge